Decoy Therapeutics Inc. (DCOY)
NASDAQ: DCOY · Real-Time Price · USD
4.820
-0.330 (-6.41%)
At close: May 13, 2026, 4:00 PM EDT
4.750
-0.070 (-1.45%)
After-hours: May 13, 2026, 7:42 PM EDT
Decoy Therapeutics Market Cap
Decoy Therapeutics has a market cap or net worth of $2.56 million as of May 13, 2026. Its market cap has increased by 110.44% in one year.
Market Cap
2.56M
Enterprise Value
-5.26M
1-Year Change
110.44%
Ranking
Category
Stock Price
$4.82
Market Cap Chart
Since July 22, 2019, Decoy Therapeutics's market cap has decreased from $44.18M to $2.56M, a decrease of -94.20%. That is a compound annual growth rate of -34.16%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 12, 2026 | 2.74M | -33.86% |
| Dec 31, 2025 | 4.14M | 56.21% |
| Dec 31, 2024 | 2.65M | 3.58% |
| Dec 29, 2023 | 2.56M | -26.55% |
| Dec 30, 2022 | 3.49M | -84.43% |
| Dec 31, 2021 | 22.39M | 3.40% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Jul 22, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Revelation Biosciences | 3.64M |
| Ensysce Biosciences | 3.54M |
| SciSparc | 3.43M |
| GRI Bio | 3.27M |
| Valion Bio | 3.19M |
| Calidi Biotherapeutics | 3.05M |
| Virax Biolabs Group | 2.97M |
| Soligenix | 2.89M |